PONZONI, MAURILIO
 Distribuzione geografica
Continente #
AS - Asia 8.440
NA - Nord America 5.128
EU - Europa 3.524
SA - Sud America 2.965
AF - Africa 182
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 2
Totale 20.263
Nazione #
US - Stati Uniti d'America 4.871
SG - Singapore 3.491
BR - Brasile 2.453
CN - Cina 2.135
HK - Hong Kong 1.321
SE - Svezia 1.171
VN - Vietnam 804
IT - Italia 557
RU - Federazione Russa 466
DE - Germania 386
AR - Argentina 218
GB - Regno Unito 189
FI - Finlandia 176
AT - Austria 120
IN - India 111
MX - Messico 110
EC - Ecuador 99
CA - Canada 98
IE - Irlanda 97
ID - Indonesia 93
JP - Giappone 85
FR - Francia 75
BD - Bangladesh 72
ZA - Sudafrica 59
NL - Olanda 56
PL - Polonia 56
CO - Colombia 53
TR - Turchia 50
ES - Italia 49
PY - Paraguay 46
IQ - Iraq 44
MA - Marocco 37
VE - Venezuela 30
CL - Cile 29
UA - Ucraina 26
SA - Arabia Saudita 25
KE - Kenya 22
PK - Pakistan 22
UZ - Uzbekistan 20
AU - Australia 18
IR - Iran 18
KR - Corea 18
EG - Egitto 17
PE - Perù 17
TN - Tunisia 17
PT - Portogallo 14
AE - Emirati Arabi Uniti 13
UY - Uruguay 12
BE - Belgio 11
DZ - Algeria 11
IL - Israele 11
DO - Repubblica Dominicana 10
LB - Libano 10
LT - Lituania 9
AL - Albania 8
HN - Honduras 8
KW - Kuwait 8
KZ - Kazakistan 8
OM - Oman 8
BO - Bolivia 7
CZ - Repubblica Ceca 7
AZ - Azerbaigian 6
BY - Bielorussia 6
CH - Svizzera 6
GT - Guatemala 6
JM - Giamaica 6
JO - Giordania 6
MY - Malesia 6
PS - Palestinian Territory 6
SY - Repubblica araba siriana 6
TW - Taiwan 6
GG - Guernsey 5
LV - Lettonia 5
NO - Norvegia 5
NP - Nepal 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BH - Bahrain 4
CI - Costa d'Avorio 4
ET - Etiopia 4
GE - Georgia 4
HU - Ungheria 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
RS - Serbia 4
BG - Bulgaria 3
CY - Cipro 3
NG - Nigeria 3
PA - Panama 3
PH - Filippine 3
QA - Qatar 3
TT - Trinidad e Tobago 3
AM - Armenia 2
AO - Angola 2
KG - Kirghizistan 2
KH - Cambogia 2
LK - Sri Lanka 2
MM - Myanmar 2
SC - Seychelles 2
SV - El Salvador 2
Totale 20.239
Città #
Dallas 1.603
Singapore 1.347
Hong Kong 1.314
Shanghai 577
Hefei 510
Ashburn 477
Lawrence 457
Princeton 457
Ho Chi Minh City 322
Beijing 250
New York 215
São Paulo 204
Milan 169
Hanoi 146
Moscow 137
Nuremberg 136
Helsinki 121
Los Angeles 111
Dublin 96
Rio de Janeiro 90
Munich 78
Boardman 73
Tokyo 61
Vienna 56
Belo Horizonte 54
Brooklyn 44
Biên Hòa 42
Warsaw 42
Brasília 41
Turku 38
Guayaquil 37
Santa Clara 37
Montreal 36
Rome 36
Denver 35
London 35
Poplar 35
Chennai 34
Curitiba 34
Guangzhou 32
Porto Alegre 31
The Dalles 31
Johannesburg 30
Atlanta 27
Campinas 27
Houston 27
Quito 27
Salvador 27
Toronto 27
Haiphong 26
Boston 25
Frankfurt am Main 25
Mexico City 24
Orem 24
Phoenix 24
Sorocaba 24
Stockholm 24
Asunción 23
Da Nang 23
Jakarta 23
Chicago 21
Goiânia 21
Nairobi 21
Osasco 21
Seattle 21
Cesano Boscone 20
Pune 20
Columbus 19
Juiz de Fora 19
Washington 19
Hải Dương 18
Leicester 18
San Francisco 18
Shenzhen 18
Thái Bình 18
Dhaka 17
Guarulhos 17
Tashkent 17
Ankara 16
Joinville 16
Manaus 16
Ninh Bình 16
Tianjin 16
Amsterdam 15
Hangzhou 15
Lappeenranta 15
Querétaro 15
Buenos Aires 14
Maceió 14
Recife 14
Ribeirão Preto 14
Baghdad 13
Bologna 13
Contagem 13
Duque de Caxias 13
Falkenstein 13
São José dos Campos 13
Thái Nguyên 13
Cabo Frio 12
Manchester 12
Totale 10.792
Nome #
Definition, diagnosis, and management of intravascular large B-Cell lymphoma: Proposals and perspectives from an international consensus meeting 281
Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma 207
3D-culture of CLL cells in bioreactor identifies the bone marrow as a key regulator of HS1 function in response to Ibrutinib 182
[Clinical value of spleen autograft]. FT Considerazioni sul valore clinico dell'autoinnesto di milza 153
EA4HP24-LYWS-293 An indolent EBV-related clonal T-cell proliferation presenting as chronic rhinosinusitis 145
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 131
BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome 111
A multicenter study of treatment of primary CNS lymphoma 106
A Mechanistic Role For Mir-126, a Hematopoietic Stem Cell Microrna, In Acute Leukemias 102
A MULTICENTER TRIAL ASSESSING FEASIBILITY AND EFFICACY OF A COMBINATION OF HIGH-DOSE METHOTREXATE, CYTARABINE AND THIOTEPA IN PATIENTS WITH PRIMARY CNS LYMPHOMA: IMPACT ON OUTCOME OF CYTARABINE DOSE 99
A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progression 97
3D co-culture model of chronic lymphocytic leukemia bone marrow microenvironment predicts patient-specific response to mobilizing agents 97
A PHASE II STUDY TO INVESTIGATE THE PREVALENCE OF INFECTIOUS AGENTS IN OCULAR ADNEXAE MARGINAL ZONE LYMPHOMA (OAMZL) AND THE EFFICACY OF ANTIBIOTIC THERAPY (IELSG#27 TRIAL) 96
ABS0671 IgG4-RELATED DISEASE IN OVERLAP WITH IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE: CLINICAL-PATHOLOGICAL CHARACTERISTICS AND THERAPEUTIC IMPLICATIONS OF AN ORPHAN DISEASE 95
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 94
A novel Rag2(-/-)gamma(-/-)(c)-xenograft model of human CLL 93
A Novel t(5;7)(q31;q21)/CDK6::IL3 in Immature T-cell Acute Lymphoblastic Leukemia With IL3 Expression and Eosinophilia 90
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency 90
CLINICAL AND PATHOLOGICAL CHARACTERISTICS OF HIGH-GRADE B-CELL LYMPHOMAS TRANSFORMED FROM INDOLENT LYMPHOMAS IN HIV-NEGATIVE AND HIV-POSITIVE PATIENTS 88
A bitter effect: thrombocytopenia induced by a quinidine-containing beverage 85
A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL 84
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease 82
A screening study of Chlamydia psittaci infection in 172 cases of nodal and extranodal non-hodgkin lymphomas 82
A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the “CARMEN” phase II trial 81
A virtual tissue bank for primary central nervous system lymphomas in immunocompetent individuals 81
A Six-Month Regimen of Oral Clarithromycin Is a Feasible and Active Therapy for Patients with Relapsed/Refractory Marginal Zone B-Cell Lymphoma of MALT-Type 79
Anti-CD20 monoclonal antibody (Rituximab) in gastric extranodal marginal zone (MALT) non-Hodgkin's lymphoma (NHL) patients: Clinical and biological results (Phase II study). 79
Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models 79
THREE-HOUR INFUSION OF METHOTREXATE AT 3 g/m2 SIGNIFICANTLY REDUCES CNS RELAPSES AND IMPROVES SURVIVAL IN PATIENTS WITH LARGE B-CELL LYMPHOMAS AND INCREASED CNS RISK 79
Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy 78
A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit: A position paper from the Italian Group of Haematopathology (G.I.E.) 77
Chronic lymphocytic leukemia: the pathologist's view of lymph node microenvironment 75
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer 75
Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia 73
Follicular helper T cell signature of replicative exhaustion, apoptosis and senescence in common variable immunodeficiency 72
A woman and her canary: a tale of chlamydiae and lymphomas 71
Chlamydia infection and lymphoma: Multiple detection methods highlight an association beyond lymphomas of the ocular adnexa 71
Bone marrow metastases: a systematic review of a neglected involvement in malignant melanoma 70
B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. 70
CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome 69
SHORT-TERM DOSE-DENSE “CARMEN” THERAPY IS BETTER TOLERATED AND EVENLY EFFECTIVE THAN OTHER INTENSIFIED REGIMENS IN HIV- AND HIV+ PATIENTS WITH BURKITT LYMHOMA 69
A PHASE II TRIAL TO INVESTIGATE THE LINK WITH INFECTIOUS AGENTS IN OCULAR ADNEXAL MARGINAL ZONE LYMPHOMA, ESPECIALLY WITH CHLAMYDIA SPECIES, AND THE ANTINEOPLASTIC EFFECTS OF DOXYCYCLINE (IELSG#27) 69
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease 68
Lack of TIR8/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models 67
Activity of rituximab in extranodal marginal zone lymphomas (MALT-type). 67
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation 66
HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment 66
Graft-versus leukemia effect of HLA-haploidentical central-memory T cells expanded with leukemic APCs and modified with a suicide gene 66
Bone marrow as an alternative site for islet transplantation 65
A reappraisal of the diagnostic and therapeutic management of uncommon histologies of primary ocular adnexal lymphoma 65
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: Results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial 64
Aggressive B-cell lymphoma with MYC/TP53 dual alterations displays distinct clinicopathobiological features and response to novel targeted agents 62
Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis 62
Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort 61
Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies 60
EZN-2208 treatment suppresses chronic lymphocytic leukaemia by interfering with environmental protection and increases response to fludarabine 59
MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study 59
Kikuchi-Fujimoto Disease Shows Frequent T-Cell Antigen Loss and MUM1 Expression in Cytotoxic T Cells: a Multi-institutional Italian Study 58
The impact of histopathologic diagnosis on the proper management of testis neoplasms 58
Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation 58
Bone Marrow Histopathology in the Diagnostic Evaluation of Splenic Marginal-zone and Splenic Diffuse Red Pulp Small B-cell Lymphoma: A Reliable Substitute for Spleen Histopathology? 58
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: Final results of a phase 2 trial 58
Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center 58
CD4+T cells sustain aggressive chronic lymphocytic leukemia in Em- TCL1 mice through a CD40L-independent mechanism 58
Role of next-generation sequencing in acquired amegakaryocytic thrombocytopenic purpura 57
Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells 57
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes 57
Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia 57
Plasma cells require autophagy for sustainable immunoglobulin production 56
Accelerated progression to AIDS in macaques coinfected with simian immunodeficiency virus and human herpesvirus 6A 56
Angiopoietin-2 in Bone Marrow milieu promotes Multiple Myeloma-associated angiogenesis 56
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma 56
Primary central nervous system lymphoma 56
Ex vivo gene therapy with lentiviral vectors rescues adenosine deaminase (ADA)-deficient mice and corrects their immune and metabolic defects 55
Cyclin D3 immunoreactivity (IR) is an independent predictor of survival and drives the correct assessment of p27(KIP1) IR prognostic role in primary gastric lymphomas (PGL). 55
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease 55
FEASIBILITY AND EFFICACY OF CHLAMYDIA PSITTACI ERADICATION WITH PROLONGED DOXYCYCLINE THERAPY IN LOCALIZED OCULAR ADNEXAE MARGINAL ZONE LYMPHOMA (OAMZL): 7-YEAR RESULTS OF THE IELSG39 MULTICENTER TRIAL 54
SNP-Arrays Provide New Insights Into the Pathogenesis of Post-Transplant Diffuse Large B-Cell Lymphoma (PT-DLBCL) 54
Proceedings: Congresso Annaule di Anatomia Patologica SIAPEC-IAP 2019 53
RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY (CHT) WITH HIGH-DOSE METHOTREXATE (MTX) ALONE OR ASSOCIATED WITH HIGH-DOSE CYTARABINE (ARAC) FOR PATIENTS (PTS) WITH PRIMARY CNS LYMPHOMA (PCNSL): THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG) #20 TRIAL 53
Modeling Multiple Myeloma-Bone Marrow interactions and response to drugs in a 3D surrogate microenvironment 53
Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VK*MYC model of multiple myeloma 53
Central nervous system marginal zone B-cell lymphoma associated with chlamydophila psittaci infection 52
Atypical presentation of Churg-Strauss syndrome or an undescribed hypereosinophilic disease? 51
Autologous Pancreatic Islet Transplantation in Human Bone Marrow 51
Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications 51
ORBIT IRRADIATION AS SALVAGE TREATMENT FOR PATIENTS WITH OCULAR ADNEXAL MALT LYMPHOMA (OAML) RELAPSED AFTER OR REFRACTORY TO CHLAMYDIA PSITTACI-ERADICATING ANTIBIOTIC THERAPY 50
ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapies 50
Erratum: Autologous pancreatic islet transplantation in human bone marrow (Diabetes (2013) 62 (3523-3531)) 50
Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial 50
Clinical Relevance of the Dose of Cytarabine in the Upfront Treatment of Primary CNS Lymphomas with Methotrexate-Cytarabine Combination 50
Induction of iron excess restricts malignant plasma cells expansion and potentiates bortezomib effect in models of multiple myeloma 50
Chlamydia infection and lymphomas: association beyond ocular adnexal lymphomas highlighted by multiple detection methods 50
Implications of recent molecular achievements in early diagnosis and precision treatments for primary CNS lymphoma 49
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 49
Calreticulin as a novel B-cell receptor antigen in chronic lymphocytic leukemia 49
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation 49
AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma 49
Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset 8 49
Angiogenesis Associated with Alterations of the Bone Marrow Microenvironment Predicts Multiple Myeloma Progression to Symptomatic Disease in Mice and Humans 49
Totale 7.361
Categoria #
all - tutte 174.690
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 174.690


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202160 0 0 0 0 0 5 49 0 5 1 0 0
2021/2022303 0 0 2 146 11 12 26 41 10 15 7 33
2022/20232.400 1.054 461 121 10 21 278 117 164 90 27 22 35
2023/20241.220 70 66 97 129 118 223 63 92 32 57 67 206
2024/20256.419 796 102 90 181 169 500 737 513 1.234 1.092 485 520
2025/202610.104 1.425 1.979 2.109 3.205 1.289 97 0 0 0 0 0 0
Totale 20.610